Fred Rosen

1.7k total citations
22 papers, 1.3k citations indexed

About

Fred Rosen is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Fred Rosen has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Otorhinolaryngology, 11 papers in Oncology and 8 papers in Surgery. Recurrent topics in Fred Rosen's work include Head and Neck Cancer Studies (12 papers), Head and Neck Surgical Oncology (6 papers) and Cancer Diagnosis and Treatment (3 papers). Fred Rosen is often cited by papers focused on Head and Neck Cancer Studies (12 papers), Head and Neck Surgical Oncology (6 papers) and Cancer Diagnosis and Treatment (3 papers). Fred Rosen collaborates with scholars based in United States, Canada and Philippines. Fred Rosen's co-authors include Everett E. Vokes, Kerstin Stenson, Ezra E.W. Cohen, Dezheng Huo, Wendy Recant, Walter M. Stadler, Daniel J. Haraf, Bruce Brockstein, Bharat B. Mittal and Merrill S. Kies and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Clinical Cancer Research.

In The Last Decade

Fred Rosen

21 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred Rosen United States 13 846 669 570 556 241 22 1.3k
Mary Ellyn Witt United States 17 997 1.2× 607 0.9× 552 1.0× 710 1.3× 237 1.0× 24 1.5k
A A Forastiere United States 9 1.5k 1.8× 911 1.4× 605 1.1× 1.1k 2.1× 232 1.0× 14 2.0k
T. Vuong Canada 6 1.4k 1.7× 776 1.2× 532 0.9× 1.1k 1.9× 137 0.6× 10 1.7k
Emmanuel Guardiola France 18 240 0.3× 369 0.6× 241 0.4× 232 0.4× 108 0.4× 36 726
S. Bourdin France 15 214 0.3× 326 0.5× 432 0.8× 264 0.5× 81 0.3× 40 887
J.L. Geiger United States 16 526 0.6× 681 1.0× 243 0.4× 469 0.8× 235 1.0× 92 1.3k
Tomasz Rutkowski Poland 17 419 0.5× 260 0.4× 358 0.6× 247 0.4× 233 1.0× 102 981
S. Racadot France 16 435 0.5× 290 0.4× 330 0.6× 375 0.7× 81 0.3× 72 863
Olivier Capitain France 15 114 0.1× 535 0.8× 269 0.5× 160 0.3× 115 0.5× 59 826

Countries citing papers authored by Fred Rosen

Since Specialization
Citations

This map shows the geographic impact of Fred Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Rosen more than expected).

Fields of papers citing papers by Fred Rosen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Rosen. The network helps show where Fred Rosen may publish in the future.

Co-authorship network of co-authors of Fred Rosen

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Rosen. A scholar is included among the top collaborators of Fred Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Rosen. Fred Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosen, Fred, et al.. (2020). Impact of failure to thrive on inpatient mortality and resource utilization in patients with head and neck cancer: A nationwide analysis.. Journal of Clinical Oncology. 38(15_suppl). e18531–e18531. 1 indexed citations
2.
Gupta, Shweta, et al.. (2019). HIV associated head and neck cancers in an inner-city minority population.. Journal of Clinical Oncology. 37(15_suppl). e13124–e13124. 1 indexed citations
3.
Patel, Urjeet A., et al.. (2016). Depression and smoking patterns among head and neck cancer patients in an inner city minority population.. Journal of Clinical Oncology. 34(3_suppl). 184–184. 1 indexed citations
4.
5.
Cohen, Ezra E.W., Dezheng Huo, Daniel J. Haraf, et al.. (2009). Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy. Head & Neck. 31(8). 1013–1021. 47 indexed citations
6.
Patel, Urjeet A., et al.. (2009). Poor radiotherapy compliance predicts persistent regional disease in advanced head/neck cancer. The Laryngoscope. 119(3). 528–533. 21 indexed citations
7.
Patel, Urjeet A., et al.. (2006). Advanced Stage of Head and Neck Cancer at a Tertiary‐Care County Hospital. The Laryngoscope. 116(8). 1473–1477. 22 indexed citations
8.
Cohen, Ezra E.W., Daniel J. Haraf, Marcy A. List, et al.. (2006). High Survival and Organ Function Rates After Primary Chemoradiotherapy for Intermediate-Stage Squamous Cell Carcinoma of the Head and Neck Treated in a Multicenter Phase II Trial. Journal of Clinical Oncology. 24(21). 3438–3444. 17 indexed citations
9.
Argiris, Athanassios, Kerstin Stenson, Bruce Brockstein, et al.. (2004). Neck dissection in the combined‐modality therapy of patients with locoregionally advanced head and neck cancer. Head & Neck. 26(5). 447–455. 115 indexed citations
10.
Argiris, Athanassios, Bruce Brockstein, Daniel J. Haraf, et al.. (2004). Competing Causes of Death and Second Primary Tumors in Patients with Locoregionally Advanced Head and Neck Cancer Treated with Chemoradiotherapy. Clinical Cancer Research. 10(6). 1956–1962. 141 indexed citations
11.
12.
Haraf, Daniel J., Fred Rosen, Kerstin Stenson, et al.. (2003). Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.. PubMed. 9(16 Pt 1). 5936–43. 63 indexed citations
13.
Vokes, Everett E., Kerstin Stenson, Fred Rosen, et al.. (2003). Weekly Carboplatin and Paclitaxel Followed by Concomitant Paclitaxel, Fluorouracil, and Hydroxyurea Chemoradiotherapy: Curative and Organ-Preserving Therapy for Advanced Head and Neck Cancer. Journal of Clinical Oncology. 21(2). 320–326. 186 indexed citations
14.
Rosen, Fred, Daniel J. Haraf, Merrill S. Kies, et al.. (2003). Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.. PubMed. 9(5). 1689–97. 62 indexed citations
15.
Cohen, Ezra E.W., Fred Rosen, Walter M. Stadler, et al.. (2003). Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. Journal of Clinical Oncology. 21(10). 1980–1987. 491 indexed citations
16.
Lad, Thomas E., et al.. (2000). Phase II Trial of Aminocamptothecin (9-AC/DMA) in Patients with Advanced Squamous Cell Head and Neck Cancer. Investigational New Drugs. 18(3). 261–263. 13 indexed citations
17.
Reddy, Sarada P., et al.. (1995). Radiotherapy Alone Compared with Radiotherapy and Chemotherapy in Patients with Squamous Cell Carcinoma of the Esophagus. American Journal of Clinical Oncology. 18(5). 376–381. 5 indexed citations
18.
Rosen, Fred, Everett E. Vokes, Thomas E. Lad, et al.. (1995). Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. Investigational New Drugs. 13(3). 249–252. 3 indexed citations
19.
Rosen, Fred & C. Ezrin. (1966). Embryology of the Thyrotroph. The Journal of Clinical Endocrinology & Metabolism. 26(12). 1343–1345. 13 indexed citations
20.
Rosen, Fred, et al.. (1957). Evaluation of the Iodine Pregnancy Test. American Journal of Obstetrics and Gynecology. 74(2). 314–317. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Ellyn Witt Breakdown of academic impact, for papers by A A Forastiere Breakdown of academic impact, for papers by T. Vuong Breakdown of academic impact, for papers by Emmanuel Guardiola Breakdown of academic impact, for papers by S. Bourdin Breakdown of academic impact, for papers by J.L. Geiger Breakdown of academic impact, for papers by Tomasz Rutkowski Breakdown of academic impact, for papers by S. Racadot Breakdown of academic impact, for papers by Olivier Capitain
Rankless by CCL
2026